InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ABVC BIOPHARMA, INC.

ABVC Clue Score38
United States Fiscal year ends December CIK 0001173313
$1.00 +2.04% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.00 −54.13% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−4.0Net income−4.1EPS, diluted−0.02Fiscal year 2017Operating income−4.1Net income−4.2EPS, diluted−0.02Fiscal year 2018Revenue0.0Operating income−2.8Net income−6.1EPS, diluted−0.02Fiscal year 2019Revenue0.7 +9,988.0%Operating income−3.5Net income−3.9Fiscal year 2020Revenue0.5 −31.2%Operating income−8.5Net income−10.6EPS, diluted−0.50Fiscal year 2021Revenue0.4 −26.3%Operating income−11.7Net income−12.8EPS, diluted−0.51Fiscal year 2022Revenue1.0 +172.6%Operating income−15.1Net income−16.4EPS, diluted−5.19Fiscal year 2023Revenue0.2 −84.3%Operating income−6.8Net income−7.8EPS, diluted−1.80Fiscal year 2024Revenue0.5 +234.3%Operating income−4.7Net income−4.9EPS, diluted−0.42Fiscal year 2025Operating income−7.2Net income−7.9EPS, diluted−0.39
FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.0 0.7 0.5 0.4 1.0 0.2 0.5 n/a
Growth +9,988.0% −31.2% −26.3% +172.6% −84.3% +234.3%
Operating income −4.0 −4.1 −2.8 −3.5 −8.5 −11.7 −15.1 −6.8 −4.7 −7.2
Net income −4.1 −4.2 −6.1 −3.9 −10.6 −12.8 −16.4 −7.8 −4.9 −7.9
Growth
EPS, diluted −0.02 −0.02 −0.02 n/a −0.50 −0.51 −5.19 −1.80 −0.42 −0.39

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Fiscal year 2017Fiscal year 2018Gross margin−2,563.6%Operating margin−40,031.1%Net margin−87,184.2%Fiscal year 2019Gross margin97.1%Operating margin−492.9%Net margin−560.5%Fiscal year 2020Gross margin96.1%Operating margin−1,760.9%Net margin−2,193.1%Fiscal year 2021Gross margin98.6%Operating margin−3,290.1%Net margin−3,608.5%Free cash flow margin−2,140.3%Fiscal year 2022Gross margin70.5%Operating margin−1,558.5%Net margin−1,693.5%Free cash flow margin−775.2%Fiscal year 2023Gross margin−98.1%Operating margin−4,439.2%Net margin−5,109.3%Free cash flow margin−2,760.6%Fiscal year 2024Gross margin99.9%Operating margin−923.3%Net margin−962.1%Fiscal year 2025
FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a −2,563.6% 97.1% 96.1% 98.6% 70.5% −98.1% 99.9% n/a
Operating margin n/a n/a −40,031.1% −492.9% −1,760.9% −3,290.1% −1,558.5% −4,439.2% −923.3% n/a
Net margin n/a n/a −87,184.2% −560.5% −2,193.1% −3,608.5% −1,693.5% −5,109.3% −962.1% n/a
Free cash flow margin n/a n/a n/a n/a n/a −2,140.3% −775.2% −2,760.6% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−1.6Fiscal year 2017Operating cash flow−1.5Fiscal year 2018Operating cash flow−0.9Fiscal year 2019Operating cash flow−3.1Fiscal year 2020Operating cash flow−4.6Fiscal year 2021Operating cash flow−7.6Capital expenditure−0.0Free cash flow−7.6Fiscal year 2022Operating cash flow−7.4Capital expenditure−0.1Free cash flow−7.5Fiscal year 2023Operating cash flow−4.2Capital expenditure−0.0Free cash flow−4.2Fiscal year 2024Operating cash flow−1.8Fiscal year 2025Operating cash flow−3.0
FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −1.6 −1.5 −0.9 −3.1 −4.6 −7.6 −7.4 −4.2 −1.8 −3.0
Capital expenditure n/a n/a n/a n/a n/a −0.0 −0.1 −0.0 n/a n/a
Free cash flow n/a n/a n/a n/a n/a −7.6 −7.5 −4.2 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash0.2Shareholders’ equity−1.4Fiscal year 2017Cash0.1Shareholders’ equity−1.8Fiscal year 2018Cash0.2Shareholders’ equity−5.7Fiscal year 2019Cash0.1Shareholders’ equity−0.2Fiscal year 2020Cash4.3Shareholders’ equity3.4Fiscal year 2021Cash5.8Shareholders’ equity8.8Fiscal year 2022Cash0.1Shareholders’ equity3.1Fiscal year 2023Cash0.1Shareholders’ equity1.6Fiscal year 2024Cash0.2Shareholders’ equity1.2Fiscal year 2025Cash0.7Shareholders’ equity11.1
FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.2 0.1 0.2 0.1 4.3 5.8 0.1 0.1 0.2 0.7
Shareholders’ equity −1.4 −1.8 −5.7 −0.2 3.4 8.8 3.1 1.6 1.2 11.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Sep 2017 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a −2,563.6% 97.1% 96.1% 98.6% 70.5% −98.1% 99.9% n/a
n/a n/a −40,031.1% −492.9% −1,760.9% −3,290.1% −1,558.5% −4,439.2% −923.3% n/a
n/a n/a −92,432.8% −571.5% −2,238.7% −3,150.9% −1,599.8% −5,264.6% −1,053.7% n/a
n/a n/a −87,184.2% −560.5% −2,193.1% −3,608.5% −1,693.5% −5,109.3% −962.1% n/a
n/a n/a n/a n/a n/a −2,140.3% −775.2% −2,760.6% n/a n/a
Spending
n/a n/a 14,213.9% 149.4% 113.8% 282.1% 277.7% 697.3% 35.2% n/a
n/a n/a 22,839.5% 437.4% 884.7% 1,615.0% 625.7% 3,521.8% 443.8% n/a
n/a n/a n/a n/a n/a 4.9% 12.3% 13.9% n/a n/a
Returns
n/a n/a n/a n/a −308.1% −145.2% −530.0% −501.1% −399.9% −71.2%
−147.8% −160.5% −102.1% −56.8% −91.3% −93.7% −171.4% −100.0% −65.0% −37.5%
Balance and payout
150.6% 166.5% 189.9% 101.8% 77.1% 35.2% 66.2% 83.9% 90.4% 36.9%